ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming

October 7, 1983

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High

March 5, 1999

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

Neutron Clinical Trials Contract Concept Approved

June 22, 1984

In Brief: James Downing named CEO of St. Jude

June 27, 2014